Cipla launches drug to treat H1N1 virus

Published on Wed, Nov 11, 2009 at 12:54 |  Source : Reuters

Updated at Wed, Nov 11, 2009 at 13:08  

50531 Investors following Cipla. Share this News with them.
0
0
Share on Tumblr
Cipla launches drug to treat H1N1 virus

ALSO READ

Drug maker Cipla on Wednesday launched its generic version of Roche's Tamiflu, used in the treatment of the H1N1 swine flu virus, the firm said in a statement.

Cipla's Oseltamivir brand, called Antiflu, will cost Rs 475 for 10 capsules, with 75 ml syrup will be similarly priced.

Cipla's drug is also pre-qualified by the World Health Organisation.

  

More on Moneycontrol

Trending News

Business News

Next-gen Macbooks may come with Retina display
Will RBI regulation prevent a gold loan bubble? "Will RBI regulation prevent a gold loan bubble?"

Obama On US Budget Proposes Replacing AMT With Buffett Rule

The latest earning numbers FIRST on CNBC-TV18
Videos
Interviews

Feb 13 2012, 22:41 | Source: CNBC-TV18

Govt, TRAI should map solutions for telecom sector: Experts  

Feb 13 2012, 19:27 | Source: CNBC-TV18

'Diverse offerings in power helping to withstand headwinds'  

Subscribe to

Moneycontrol Newsletters

Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!

Follow moneycontrol.com